Megan graduated from Yale University with a BS in Molecular & Cellular Biology and from Wharton School of Business with an MBA in Healthcare Management & Corporate Strategy. She has had a 25-year career in the biopharma industry across 3 companies. Her roles have included both corporate functions (Business Development, Finance, and Strategy), with a focus on M&A, and commercial functions (marketing, market access, and sales leadership). Most recently, Megan has held Strategy & Operations positions in European and Worldwide functions. Her experience includes larger team leadership across multiple geographies/cultures. She thrives in areas of disruptive transformation and excels at change leadership and consortium-building for innovation.